These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Harbott J; Viehmann S; Borkhardt A; Henze G; Lampert F Blood; 1997 Dec; 90(12):4933-7. PubMed ID: 9389711 [TBL] [Abstract][Full Text] [Related]
27. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia]. Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427 [TBL] [Abstract][Full Text] [Related]
28. Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia. Kobayashi H; Satake N; Kaneko Y Leuk Lymphoma; 1997 Dec; 28(1-2):43-50. PubMed ID: 9498702 [TBL] [Abstract][Full Text] [Related]
29. [Study of the childhood acute lymphoblastic leukemia with t(12;21)]. Lin D; Liu SH; Zhu XF; Bo LJ; Li CW; Chen YM; Liu XP; Qin S; Dai Y; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):17-21. PubMed ID: 14990071 [TBL] [Abstract][Full Text] [Related]
30. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. Ford AM; Palmi C; Bueno C; Hong D; Cardus P; Knight D; Cazzaniga G; Enver T; Greaves M J Clin Invest; 2009 Apr; 119(4):826-36. PubMed ID: 19287094 [TBL] [Abstract][Full Text] [Related]
31. Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Pallisgaard N; Clausen N; Schroder H; Hokland P Genes Chromosomes Cancer; 1999 Dec; 26(4):355-65. PubMed ID: 10534771 [TBL] [Abstract][Full Text] [Related]
32. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia]. Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858 [TBL] [Abstract][Full Text] [Related]
33. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464 [TBL] [Abstract][Full Text] [Related]
34. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia. Tiensiwakul P Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290 [TBL] [Abstract][Full Text] [Related]
35. Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission. Endo C; Oda M; Nishiuchi R; Seino Y Pediatr Int; 2003 Jun; 45(3):275-80. PubMed ID: 12828580 [TBL] [Abstract][Full Text] [Related]
36. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Tsuzuki S; Seto M; Greaves M; Enver T Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899 [TBL] [Abstract][Full Text] [Related]
37. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150 [TBL] [Abstract][Full Text] [Related]
38. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188 [TBL] [Abstract][Full Text] [Related]
39. Molecular detection of TEL-AML1 transcripts as a diagnostic tool and for monitoring of minimal residual disease in B-lineage childhood acute lymphoblastic leukemia. Park HJ; Lee KE; Um JM; Choe SY; Chi XZ; Lee JA; Shin HY; Ahn HS; Bae SC Mol Cells; 2000 Feb; 10(1):90-5. PubMed ID: 10774753 [TBL] [Abstract][Full Text] [Related]
40. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia. de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]